ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Aptevo Therapeutics Inc

Aptevo Therapeutics Inc (APVO)

0.8287
-0.0093
(-1.11%)
Closed June 12 4:00PM
0.8287
0.00
( 0.00% )
Pre Market: 4:34AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.8287
Bid
0.7901
Ask
0.83
Volume
175
0.00 Day's Range 0.00
0.67 52 Week Range 80.96
Market Cap
Previous Close
0.8287
Open
-
Last Trade Time
04:05:07
Financial Volume
-
VWAP
-
Average Volume (3m)
905,372
Shares Outstanding
533,464
Dividend Yield
-
PE Ratio
-0.03
Earnings Per Share (EPS)
-32.64
Revenue
-
Net Profit
-17.41M

About Aptevo Therapeutics Inc

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was $0.83. Over the last year, Aptevo Therapeutics shares have traded in a share price range of $ 0.67 to $ 80.96.

Aptevo Therapeutics currently has 533,464 shares outstanding. The market capitalization of Aptevo Therapeutics is $442,775 . Aptevo Therapeutics has a price to earnings ratio (PE ratio) of -0.03.

APVO Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.02212.739895859160.80660.890.7809991870.82927539CS
40.00630.7660505836580.82240.890.7021551950.78004183CS
12-4.2013-83.52485089465.035.040.679053721.1686338CS
26-7.0913-89.53661616167.9210.80.676530633.21492748CS
52-69.1313-98.815465980669.9680.960.6753678910.20946795CS
156-1148.8913-99.92792158091149.721397.440.67581226387.23480832CS
260-35.6869-97.73055899436.515626400.67573986414.20313736CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NCINeo Concept International Group Holdings Ltd
$ 1.15
(76.22%)
7.83M
LGHLWLion Group Holding Ltd
$ 0.0099
(45.59%)
790.36k
DUOFangDD Network Group Ltd
$ 0.8322
(36.43%)
2.3M
MOLNMolecular Partners AG
$ 6.94
(19.66%)
174.42k
PWMPrestige Wealth Inc
$ 0.92
(14.96%)
4
IONMAssure Holdings Corporation
$ 0.235
(-54.19%)
619.81k
CARACara Therapeutics Inc
$ 0.5434
(-20.03%)
3k
NAVINavient Corporation
$ 11.70
(-19.14%)
1
PTPIPetros Pharmaceuticals Inc
$ 0.4357
(-18.98%)
84.41k
PRFXPainReform Ltd
$ 0.6299
(-16.80%)
30.8k
NCINeo Concept International Group Holdings Ltd
$ 1.15
(76.22%)
7.83M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 8.35
(10.60%)
2.69M
DUOFangDD Network Group Ltd
$ 0.8322
(36.43%)
2.3M
LGVNLongeveron Inc
$ 2.08
(14.92%)
1.89M
AEMDAethlon Medical Inc
$ 0.5992
(14.66%)
1.49M

APVO Discussion

View Posts
glenn1919 glenn1919 1 month ago
APVO...................................................https://stockcharts.com/h-sc/ui?s=APVO&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Roadtojourney Roadtojourney 1 month ago
Whyy so much of dilution pos??
πŸ‘οΈ0
mikeo56 mikeo56 1 month ago
APVO looking sweet in afterhours trading.
πŸ‘οΈ0
mikeo56 mikeo56 1 month ago
Also bought in today.
1500 @.95
Let's hope for the best.
πŸ‘οΈ0
GhosTraderX GhosTraderX 1 month ago
Looks like APVO is coming off the bottom

Bought some EOD...

GhosT
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
APVO new 52 lo
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
APVO new 52 lo

πŸ‘οΈ0
stressfreeliving stressfreeliving 3 months ago
Sue for a run again this week.
πŸ‘οΈ0
Renee Renee 3 months ago
APVO: effective March 6,2024 a one for 44 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
πŸ‘οΈ0
ErnieBilco ErnieBilco 4 months ago
What news would turn this turd into gold? It's complete junk at this point and I would almost guarantee the RS will be at 44 to 1.

Went from a promising company when I bought in to nothing but junk.
πŸ‘οΈ0
BoscoLives21 BoscoLives21 4 months ago
Just traded in six figures at .150001, does a hedge fund have inside information on news coming?
$APVO
πŸ‘οΈ0
ErnieBilco ErnieBilco 6 months ago
Another turd who can't do actual work to increase the value so let's just do a RS so it looks better to those who haven't dealt with this crapper before. VOTE NO ACROSS THE BOARD IF YOU GET A BALLOT.
πŸ‘οΈ0
willlbone willlbone 7 months ago
Bid 10 cents.
πŸ‘οΈ0
BoscoLives21 BoscoLives21 7 months ago
It’s a mystery to me why we’re not trading at ten times our current level.
$APVO!!
πŸ‘οΈ0
knrorrel knrorrel 8 months ago
still red today - hope green still today
πŸ‘οΈ0
knrorrel knrorrel 8 months ago
APVO SHOULD RISING - YESTERDAY ALREADY $0.49
imho
πŸ‘οΈ0
knrorrel knrorrel 8 months ago
...then it's time to start a huge recovery today.
imho


πŸ‘οΈ0
knrorrel knrorrel 8 months ago
very nice , thx
πŸ‘οΈ0
knrorrel knrorrel 8 months ago
TIME TO BOUNCING , LET'S GOOOOO
imho


πŸ‘οΈ0
BoscoLives21 BoscoLives21 8 months ago
Alliance Global Partners initiated coverage on Aptevo on October 9th, 2023 at $4.75/ share.
πŸ‘οΈ0
jchords jchords 8 months ago
Quick spike in price.. keeping my eye on this
👍️ 1
BoscoLives21 BoscoLives21 8 months ago
Thanks for the umpteenth update! Company has compounds proven efficacious vs. cancer/leukemia, that’s why it spiked to $70 a couple of years ago. If APVO runs in the near future, remember the warrants/ APVTW…
$APVO
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
APVO new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
APVO new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
APVO new 52 week low
πŸ‘οΈ0
ErnieBilco ErnieBilco 9 months ago
It really does need some good news but I've been nibbling at these cheap shares, I have some healthy positions in the warrants which should also skyrocket on upward moves of the commons

Poco a poco ( Little by little)
πŸ‘οΈ0
BoscoLives21 BoscoLives21 9 months ago
I added as well. Need news!!
πŸ‘οΈ0
ErnieBilco ErnieBilco 9 months ago
I added in a few accounts as it dropped so news and parabolic would be fantastic
πŸ‘οΈ0
BoscoLives21 BoscoLives21 9 months ago
It’s going up! News could send this parabolic.
πŸ‘οΈ0
ErnieBilco ErnieBilco 10 months ago
What the hell is going on with APVO? Seems to be a bottomless pit.
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
APVO new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
APVO new 52 week low
πŸ‘οΈ0
ErnieBilco ErnieBilco 10 months ago
Dang, they are still beatin this thing down like a cigarette thief in a convenience store by an employee with a beatin stick.
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
APVO new 52=week low
πŸ‘οΈ0
ErnieBilco ErnieBilco 10 months ago
It appears the offering was priced fairly, did not drop as far as I expected.

Added in all accounts
πŸ‘οΈ0
ErnieBilco ErnieBilco 10 months ago
Great place to add on the offering mayhem
πŸ‘οΈ0
ErnieBilco ErnieBilco 11 months ago
I'm up 40% on my few days of owning APVO - Hoping to hold til it gains me 300% or better.

I have a bunch of bait in the water for the warrants - I really want to add to what I gots.
πŸ‘οΈ0
BoscoLives21 BoscoLives21 11 months ago
I scarfed those .015s a while back after wildly overpaying close to $2. Might try a bid at .015..
$APVO// $APVTW
πŸ‘οΈ0
ErnieBilco ErnieBilco 11 months ago
I was shocked that it filled, I usually bid too low to catch these things.

Still trying to lowball the warrants but those are harder to catch where I'm fishin my bait.
👍️ 1
BoscoLives21 BoscoLives21 11 months ago
Great scoop!
πŸ‘οΈ0
ErnieBilco ErnieBilco 11 months ago
WOW caught some .782s this morning.
πŸ‘οΈ0
ErnieBilco ErnieBilco 11 months ago
Think I'll toss my NFLX gains from today into a split between commons and more warrants. I've already banked huge gains on the warrants way way back, like years ago I think.
👍️ 1
BoscoLives21 BoscoLives21 11 months ago
Exactly, like today, home run news and it tanks. Why? Clearly being accumulated by deep pockets, because they know the science is tight. APTVW warrants are the high risk/ monster return play..
JMHO
$APVO/$APVTW
πŸ‘οΈ0
pinkslipjunkie pinkslipjunkie 2 years ago
It never does for those that hold....
Makes no sense
πŸ‘οΈ0
ErnieBilco ErnieBilco 2 years ago
Almost a 1000 times normal volume and it's given up almost all its gains, is the stock broken or just a piece of crapola?

The news certainly sounded very good so why has it tanked off its high this morning?

Makes no sense
πŸ‘οΈ0
ErnieBilco ErnieBilco 2 years ago
On December 12, 2022, Aptevo Therapeutics Inc. (β€œAptevo” or the β€œCompany”) announced that APVO436, in combination with venetoclax and azacytidine,
achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients. The data, which was presented in a poster session at the 64th American
Society of Hematology Annual Meeting and Exposition in New Orleans, also showed that APVO436, when given in combination with this standard-of-care
regimen, was observed to be generally safe and well tolerated.
Aptevo plans to initiate a Phase 2 trial in the second half of 2023 to further evaluate APVO436 in combination with venetoclax and azacitidine among frontline
and relapsed/refractory AML patients who are venetoclax treatment naïve.
πŸ‘οΈ0
ErnieBilco ErnieBilco 2 years ago
Strong move on the commons this morning let's see if that translates into a strong move on the warrants.
πŸ‘οΈ0
subslover subslover 2 years ago
Could pop today
πŸ‘οΈ0
ErnieBilco ErnieBilco 2 years ago
Looking for some positive moves with today's news.
πŸ‘οΈ0
ErnieBilco ErnieBilco 2 years ago
Run Run and don't look back just run harder and harder.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock